A method for estimating the probability of adverse drug reactions

Naranjo, C A, Busto, U, Sellers, E M, Sandor, P, Ruiz, I, Roberts, E A, Janecek, E, Domecq, C +1 more·1981·Clinical Pharmacology and Therapeutics

Cited by (1,014)

Items 201–300 of 1,014

  1. Consensus Recommendations for Systematic Evaluation of Drug–Drug Interaction Evidence for Clinical Decision Support
    Richard T. Scheife, Lisa E. Hines, Richard D. Boyce, Sophie P. Chung, Jeremiah D. Momper, Christine D. Sommer, Darrell R. Abernethy, John R. Horn, Stephen J. Sklar, Samantha K. Wong et al. · 2015 · Drug Safety
  2. Hospitalization in older patients due to adverse drug reactions – the need for a prediction tool
    Nibu Parameswaran Nair, Leanne Chalmers, Gregory Mark Peterson, Bonnie Jayne Bereznicki, Ronald Lynel Castelino, Lre Bereznicki · 2016 · Clinical Interventions in Aging
  3. Text and Data Mining Techniques in Adverse Drug Reaction Detection
    Sarvnaz Karimi, Chen Wang, Alejandro Metke‐Jimenez, Raj Gaire, Cécile L. Paris · 2015 · ACM Computing Surveys
  4. Outcomes and predictors of very stable INR control during chronic anticoagulation therapy
    Daniel M. Witt, Thomas Delate, Nathan P. Clark, Chad Martell, Thu S. Tran, Mark Andrew Crowther, David A. Garcia, Walter Ageno, Elaine M. Hylek · 2009 · Blood
  5. Characterization of Geriatric Drug-Related Hospital Readmissions
    Lisa Anne Bero, Helene Levens Lipton, Joyce Adair Bird · 1991 · Medical Care
  6. Identifying high-risk medication: a systematic literature review
    Eva Aggerholm Sædder, Birgitte Brock, Lars Peter Nielsen · 2014 · European Journal of Clinical Pharmacology
  7. Drug-Induced Nightmares
    Dennis Frank Thompson, Dana Reid Pierce · 1999 · Annals of Pharmacotherapy
  8. Linear IgA bullous dermatosis: comparison between the drug-induced and spontaneous forms
    Johan Chanal, S. Oro, Nicolás Ortonne et al. · 2013 · British Journal of Dermatology
  9. Guidelines for Submitting Adverse Event Reports for Publication
    William N. Kelly, Felix M Arellano, Joanne Barnes, Ulf Bergman, Ralph Edwards, Agustin Ignacio Fernández, Stephen B. Freedman, David I Goldsmith, Kui A Huang, Judith K. Jones et al. · 2007 · Drug Safety
  10. OAE: The Ontology of Adverse Events
    Yongqun Oliver He, Sirarat Sarntivijai, Yu Lin, Zuoshuang Xiang, Abra Guo, Shelley Zhang, Desikan Jagannathan, Luca Toldo, Cui Tao, Barry Smith · 2014 · Journal of Biomedical Semantics
  11. Drug related problems in admitted geriatric patients: the impact of clinical pharmacist interventions
    Berhane Yohannes Hailu, Derebew Fikadu Berhe, Esayas Kebede Gudina · 2020 · BMC Geriatrics
  12. New Practical Aspects of Sweet Syndrome
    Tejas P. Joshi, Sarah K. Friske, David A. Hsiou, Madeleine A. Duvic · 2022 · American Journal of Clinical Dermatology
  13. Unit-based clinical pharmacists’ prevention of serious medication errors in pediatric inpatients
    Rainu Kaushal, David Westfall Bates, Erika L. Abramson, Jane R. Soukup, Donald A. Goldmann · 2008 · American Journal of Health-System Pharmacy
  14. Readmissions and adverse drug reactions in internal medicine: the economic impact
    Harald Dormann, Antje C. Neubert, Manfred Criegee‐Rieck · 2004 · Journal of Internal Medicine
  15. Cutaneous adverse drug reactions in Indian population: A systematic review
    Tejas Kamleshbhai Patel, Sejal Thakkar, DC Sharma · 2014 · Indian Dermatology Online Journal
  16. Adverse events associated with pyrazinamide and levofloxacin in the treatment of latent multidrug-resistant tuberculosis.
    Tina Papastavros, Lisa R Dolovich, Anne Marie Holbrook · 2002 · PubMed
  17. Emergency re‐admissions to hospital due to adverse drug reactions within 1 year of the index admission
    Emma C. Davies, Christopher F. Green, David R. Mottram, Philip Rowe, Munir Pirmohamed · 2010 · British Journal of Clinical Pharmacology
  18. Colchicine Myotoxicity: Case Reports and Literature Review
    Kerry Wilbur, Mark J. Makowsky · 2004 · Pharmacotherapy The Journal of Human Pharmacology and Drug Therapy
  19. Risk and association of HLA with oxcarbazepine-induced cutaneous adverse reactions in Asians
    Chun‐Bing Chen, Yi‐Hsin Hsiao, Tony Wu et al. · 2016 · Neurology
  20. Identification of drug-specific public TCR driving severe cutaneous adverse reactions
    Ren‐You Pan, Mu-Tzu Chu, Chuang‐Wei Wang, Yun‐Shien Lee, François A. Lemonnier, Aaron W. Michels, Ryan J. Schutte, David A. Ostrov, Chun‐Bing Chen, Elizabeth Jane Phillips et al. · 2019 · Nature Communications
  21. Fish Oil Interaction with Warfarin
    Mitchell S. Buckley, Angela D Goff, Walter E Knapp · 2003 · Annals of Pharmacotherapy
  22. Bisphosphonates and Nonhealing Femoral Fractures: Analysis of the FDA Adverse Event Reporting System (FAERS) and International Safety Efforts
    Beatrice Jara-Almonte Edwards, Andrew D. Bunta, Joseph M. Lane et al. · 2013 · Journal of Bone and Joint Surgery
  23. Evidence-based review of the black-box warning for droperidol
    Cherry W. Jackson, Amy Heck Sheehan, Jennifer G. Reddan · 2007 · American Journal of Health-System Pharmacy
  24. Incidence of Medication‐Related Harm in Older Adults After Hospital Discharge: A Systematic Review
    Nikesh Parekh, Khalid Ali, Amy Theresa Page, Tom Roper, Chakravarthi Rajkumar · 2018 · Journal of the American Geriatrics Society
  25. Autoimmune uveitis: clinical, pathogenetic, and therapeutic features
    Marcella Prete, Rosanna Dammacco, Maria Celeste Fatone · 2015 · Clinical and Experimental Medicine
  26. Drug-provoked psoriasis: is it drug induced or drug aggravated?: understanding pathophysiology and clinical relevance.
    Grace K. Kim, J.Q. Del Rosso · 2010 · PubMed
  27. Causality Assessment of Drug-Induced Hepatotoxicity: Promises and Pitfalls
    Max A. Shapiro, James H. Lewis · 2007 · Clinics in Liver Disease
  28. Fatality from Administration of Labetalol and Crushed Extended-Release Nifedipine
    Joshua G. Schier, Mary Ann Howland, Robert S. Hoffman · 2003 · Annals of Pharmacotherapy
  29. Medication-Related Visits to the Emergency Department: A Prospective Study
    Mohammad J. Tafreshi, Michael J. Melby, Keith R. Kaback · 1999 · Annals of Pharmacotherapy
  30. Antinociceptive Action of Nitrous Oxide Is Mediated by Stimulation of Noradrenergic Neurons in the Brainstem and Activation of α2BAdrenoceptors
    Shigehito Sawamura, Wade S. Kingery, M. Frances Davies, Geeta S. Agashe, J. David Clark, Brian K. Kobilka, Toshizaku Hashimoto, Mervyn Maze · 2000 · Journal of Neuroscience
  31. Acute Renal Failure Associated with Vancomycin- and Tobramycin-Laden Cement in Total Hip Arthroplasty
    Benjamin N Patrick, Michael P. Rivey, Douglas R. Allington · 2006 · Annals of Pharmacotherapy
  32. Health professionals' knowledge, attitude and practices towards pharmacovigilance in Nepal
    Subish Palaian, Mohamed Izham Mohamed Ibrahim, P Mishra · 2011 · Pharmacy Practice
  33. Review of liver injury associated with dietary supplements
    Felix Stickel, Kerstin Kessebohm, Rosemarie Weimann, Helmut Karl Seitz · 2011 · Liver International
  34. A Comprehensive Description of Muscle Symptoms Associated with Lipid-Lowering Drugs
    Sylvia Franc, Sylvie Dejager, Éric Bruckert, Marina Chauvenet, Philippe Giral, Gérard Turpin · 2003 · Cardiovascular Drugs and Therapy
  35. Imatinib and Panax Ginseng : A Potential Interaction Resulting in Liver Toxicity
    Naveen Bilgi, Kimberly Bell, Ashwin N. Ananthakrishnan · 2010 · Annals of Pharmacotherapy
  36. Severe depression, suicide attempts, and ideation during the use of interferon beta by patients with multiple sclerosis
    Fragoso, Yara Dadalti, Frota, Elizabeth Regina Comini, Lopes, Juarez Silva, Noal, Janaina Silveira, Giacomo, Maria Cristina, Gomes, Sidney, Gonçalves, Marcus Vinicius Magno, da Gama, Paulo Diniz, Finkelsztejn, Alessandro · 2010 · Clinical Neuropharmacology
  37. Use of the Beers Criteria to Predict Adverse Drug Reactions Among First‐Visit Elderly Outpatients
    Chia‐Ming Chang, Pheng‐Ying Yeh Liu, Yea‐Huei Kao Yang, Yi‐Ching Yang, Chun‐Feng Wu, Feng-Hwa Lu · 2005 · Pharmacotherapy The Journal of Human Pharmacology and Drug Therapy
  38. Drug induced pancreatitis: A systematic review of case reports to determine potential drug associations
    Dianna M. Wolfe, Salmaan Kanji, Fatemeh Yazdi, Pauline Barbeau, Danielle Brittany Rice, Andrew Beck, Claire Butler, Leila Esmaeilisaraji, Becky Skidmore, David Moher et al. · 2020 · PLoS ONE
  39. Cutaneous Reactions to Drugs in Children
    Alissa R. Segal, Kevin M. Doherty, John Leggott · 2007 · PEDIATRICS
  40. Appropriateness in health care: Application to prescribing
    Stephen Buetow, Bonnie Sibbald, Judith Anne Cantrill, Shirley Halliwell · 1997 · Social Science & Medicine
  41. Reevaluating the Safety Profile of Pediatrics: A Comparison of Computerized Adverse Drug Event Surveillance and Voluntary Reporting in the Pediatric Environment
    Jeffrey M. Ferranti, Monica M. Horvath, Heidi B. Cozart, Julie Whitehurst, Julie Eckstrand · 2008 · PEDIATRICS
  42. Carbamazepine‐induced drug reaction with eosinophilia and systemic symptoms (DRESS) syndrome: report of four cases and brief review
    Maria G. Ganeva, Tanya Gancheva, R Lazarova, Jeni Troeva, Ivan Baldaranov, Ivan Vassilev, Evgenya Hristakieva, Valentina Tzaneva · 2008 · International Journal of Dermatology
  43. Potentially inappropriate drug use among hospitalised older adults: results from the CRIME study
    Matteo Tosato, Francesco Landi, Anna Maria Martone, Antonio Cherubini, Andrea Corsonello, Stefano Volpato, Roberto Bernabei, Graziano Onder, on behalf of Investigators of the CRIME Study · 2014 · Age and Ageing
  44. A review of autoimmune skin diseases in domestic animals: I – Superficial pemphigus
    Thierry Olivry · 2006 · Veterinary Dermatology
  45. Causality classification at pharmacovigilance centres in the european community
    R.H.B. Meyboom, Rene Jean Royer · 1992 · Pharmacoepidemiology and Drug Safety
  46. Adverse Drug Reactions in Older People
    Mirko Petrović, Tischa J. M. van der Cammen, Graziano Onder · 2012 · Drugs & Aging
  47. Ondansetron and the Risk of Cardiac Arrhythmias: A Systematic Review and Postmarketing Analysis
    Stephen B. Freedman, Elizabeth M. Uleryk, Maggie Rumantir, Yaron Finkelstein · 2013 · Annals of Emergency Medicine
  48. Oxypurinol-Specific T Cells Possess Preferential TCR Clonotypes and Express Granulysin in Allopurinol-Induced Severe Cutaneous Adverse Reactions
    Wen‐Hung Chung, Ren‐You Pan, Mu-Tzu Chu · 2015 · Journal of Investigative Dermatology
  49. Adverse Drug Events and Medication Errors in African Hospitals: A Systematic Review
    Alemayehu Berhane Mekonnen, Tariq M. Alhawassi, Andrew J. McLachlan, Jo-anne Elizabeth Brien · 2017 · Drugs - Real World Outcomes
  50. Severe cutaneous adverse reactions to antiepileptic drugs in Asians
    Chin‐Yi Yang, Ro‐Lan Dao, T.-J. Lee, Chun‐Wei Lu, Chun Yang, Wen‐Hung Chung, Wen‐Hung Chung · 2011 · Neurology
  51. Methadone, ciprofloxacin, and adverse drug reactions
    Karin Herrlin, Märta Segerdahl, Lars Lennart Gustafsson · 2000 · The Lancet
  52. Advances in the Diagnosis of Adverse Drug Reactions
    Claudio A. Naranjo, Neil H. Shear, Krista L. Lanctôt · 1992 · The Journal of Clinical Pharmacology
  53. Statin‐Associated Muscle‐Related Adverse Effects: A Case Series of 354 Patients
    Cham, Stephanie, Evans, Marcella A., Denenberg, Julie O., Golomb, Beatrice A. · 2010 · Pharmacotherapy: The Journal of Human Pharmacology and Drug Therapy
  54. Associations between HLA class I and cytochrome P450 2C9 genetic polymorphisms and phenytoin-related severe cutaneous adverse reactions in a Thai population
    Wichittra Tassaneeyakul, Napat Prabmeechai, Chonlaphat Sukasem et al. · 2016 · Pharmacogenetics and Genomics
  55. Drug-Induced Uveitis
    Ramana S. Moorthy, Shailaja Valluri, Lee M. Jampol · 1998 · Survey of Ophthalmology
  56. Serotonin Syndrome Resulting from Coadministration of Tramadol, Venlafaxine, and Mirtazapine
    David J. Houlihan · 2004 · Annals of Pharmacotherapy
  57. Drug Induced Steatohepatitis: An Uncommon Culprit of a Common Disease
    Liane Rabinowich, Oren Shibolet · 2015 · BioMed Research International
  58. Adverse Drug Reactions in Hospitals: A Narrative Review
    Emma C. Davies, Christopher F. Green, David R. Mottram, Munir Pirmohamed · 2007 · Current Drug Safety
  59. HERBAL SUPPLEMENTS: A POTENTIAL FOR DRUG INTERACTIONS IN TRANSPLANT RECIPIENTS
    Gary W. Barone, Bill J. Gurley, Beverley L. Ketel, Sameh R. Abul‐Ezz · 2001 · Transplantation
  60. Adverse Drug Reactions in Breastfed Infants: Less Than Imagined
    Philip O. Anderson, Stacey L. Pochop, Anthony S. Manoguerra · 2003 · Clinical Pediatrics
  61. Severe Cutaneous Adverse Reactions Related to Systemic Antibiotics
    Y.-F. Lin, Chun Yang, Sindy Hu, J.-Y. Lin, C.-Y. Rosaline Hui, Yun-Chen Tsai, T.-S. Wu, Chun‐Ta Huang, Kuo‐Chin Kao, H.-C. Hu et al. · 2014 · Clinical Infectious Diseases
  62. Clinical Practice Guideline: Safe Medication Use in the ICU
    Sandra L. Kane‐Gill, Joseph F. Dasta, Mitchell S. Buckley, Sandeep Devabhakthuni, Michael Liu, Henry Cohen, ELISABETH L. GEORGE, Anne S. Pohlman, Swati Agarwal, Elizabeth A. Henneman et al. · 2017 · Critical Care Medicine
  63. Multiple sclerosis outcomes after cancer immunotherapy
    Catherine R. García, Rani D. Jayswal, Val R. Adams, Lowell Brian Anthony, John Lee Villano · 2019 · Clinical & Translational Oncology
  64. Pharmacological recommendations for the symptomatic treatment of dementia: the Canadian Consensus Conference on the Diagnosis and Treatment of Dementia 2012
    Nathan Herrmann, Krista L. Lanctôt, David B. Hogan · 2013 · Alzheimer s Research & Therapy
  65. Treatment outcome of intravenous artesunate in patients with severe malaria in the Netherlands and Belgium
    Annemarie Rosan Kreeftmeijer-Vegter, Perry J.J. van Genderen, Leo G. Visser, Wouter F.W. Bierman, Jan Clerinx, Cees K. W. van Veldhuizen, Peter J. de Vries · 2012 · Malaria Journal
  66. Adverse events in the intensive care unit: impact on mortality and length of stay in a prospective study
    Keroulay Estebanez Roque, Teresa Tonini, Enirtes Caetano Prates Melo · 2016 · Cadernos de Saúde Pública
  67. UVEITIS AFTER THE BNT162b2 mRNA VACCINATION AGAINST SARS-CoV-2 INFECTION: A Possible Association.
    Tamar Rabinovitch, Yael Ben‐Arie‐Weintrob, Tamar Hareuveni‐Blum, Boaz Shaer, Vicktoria Vishnevskia‐Dai, Shiri Shulman, Hadas Newman, Muhammad Biadsy, Dua Masarwa, Naomi Fischer et al. · 2021 · PubMed
  68. Adverse Events Related to Drugs and Drug Withdrawal in Nursing Home Residents
    Meghan B. Cerety, John E. Cornell, Plichta Dt, Michelle Eimer · 1993 · Journal of the American Geriatrics Society
  69. Randomized, controlled, cross-over clinical trial comparing intravenous midazolam sedation with nitrous oxide sedation in children undergoing dental extractions
    Kathy Wilson, N M Girdler, Richard R. Welbury · 2003 · British Journal of Anaesthesia
  70. Long-term Sequelae of Stevens-Johnson Syndrome/Toxic Epidermal Necrolysis
    Che‐Wen Yang, Yung‐Tsu Cho, Kai-Lung Chen · 2015 · Acta Dermato Venereologica
  71. Adverse drug reactions caused by drug–drug interactions in elderly outpatients: a prospective cohort study
    Paulo Roque Obreli-Neto, Alessandro Nobili, André Oliveira Baldoni, Camilo Molino Guidoni, Divaldo Pereira de Lyra, Diogo André Pilger, Juliano Duzanski, Mauro Tettamanti, Joice Mara Cruciol-Souza, Walderez Penteado Gaeti et al. · 2012 · European Journal of Clinical Pharmacology
  72. Possible Association Between Isotretinoin and Inflammatory Bowel Disease
    Deepa Reddy, Corey Allan Siegel, Bruce E. Sands, Sunanda V. Kane · 2006 · The American Journal of Gastroenterology
  73. Plasma Concentrations of Tyrosine Kinase Inhibitors Imatinib, Erlotinib, and Sunitinib in Routine Clinical Outpatient Cancer Care
    Nienke A. G. Lankheet, Lotte M. Knapen, Jan H.M. Schellens, Jos H. Beijnen, Neeltje Steeghs, Alwin D. R. Huitema · 2013 · Therapeutic Drug Monitoring
  74. Characterizing Cefepime Neurotoxicity: A Systematic Review
    Ayesha Ashley Appa, Rupali Jain, Robert M. Rakita · 2017 · Open Forum Infectious Diseases
  75. Impact of a Renal Drug Dosing Service on Dose Adjustment in Hospitalized Patients with Chronic Kidney Disease
    Yahaya Hassan, Rowa’ Al-Ramahi, Noorizan Abd Aziz · 2009 · Annals of Pharmacotherapy
  76. Flu-like and Other Systemic Drug Reactions Among Persons Receiving Weekly Rifapentine Plus Isoniazid or Daily Isoniazid for Treatment of Latent Tuberculosis Infection in the PREVENT Tuberculosis Study
    Timothy R. Sterling, Timothy R. Sterling, Ruth N. Moro · 2015 · Clinical Infectious Diseases
  77. Adverse drug reactions to nonsteroidal anti‐inflammatory drugs, COX‐2 inhibitors and paracetamol in a paediatric hospital
    Thirza Titchen, Noel Cranswick, Sean Beggs · 2005 · British Journal of Clinical Pharmacology
  78. Factors Associated with Preventability, Predictability, and Severity of Adverse Drug Reactions
    Kheirollah Gholami, Gloria Shalviri · 1999 · Annals of Pharmacotherapy
  79. Genetic determinants of antithyroid drug-induced agranulocytosis by human leukocyte antigen genotyping and genome-wide association study
    Pei‐Lung Chen, Shyang‐Rong Shih, Pei‐Wen Wang, Ying–Chao Lin, Chen‐Chung Chu, Jung‐Hsin Lin, Szu‐Chi Chen, Ching-Chung Chang, Tien‐Shang Huang, Keh‐Sung Tsai et al. · 2015 · Nature Communications
  80. Seizures Associated with Fluoroquinolones
    Janine M Kushner, Howard J. Peckman, Clyde R Snyder · 2001 · Annals of Pharmacotherapy
  81. Acute Liver Failure with Renal Impairment Related to the Abuse of Senna Anthraquinone Glycosides
    Bénédicte Vanderperren, Michela Rizzo, Luc J.G. Angenot, Vincent Haufroid, Michel Y. Jadoul, Philippe E. Hantson · 2005 · Annals of Pharmacotherapy
  82. Development and Validation of a Risk Model for Predicting Adverse Drug Reactions in Older People during Hospital Stay: Brighton Adverse Drug Reactions Risk (BADRI) Model
    Balamurugan Tangiisuran, Greg Scutt, Jennifer M Stevenson, Juliet E. Wright, Graziano Onder, Mirko Petrović, Tischa J. M. van der Cammen, Chakravarthi Rajkumar, Graham Davies · 2014 · PLoS ONE
  83. Dabigatran-Induced Gastrointestinal Bleeding in an Elderly Patient with Moderate Renal Impairment
    Maura K. Wychowski, Peter A. Kouides · 2012 · Annals of Pharmacotherapy
  84. Neurological Adverse Effects Attributable to β-Lactam Antibiotics: A Literature Review
    Samuel Deshayes, Antoine Coquerel, Renaud Verdon · 2017 · Drug Safety
  85. GP-delivered medication review of polypharmacy, deprescribing, and patient priorities in older people with multimorbidity in Irish primary care (SPPiRE Study): A cluster randomised controlled trial
    Caroline McCarthy, Barbara Clyne, Fiona Boland, Frank Moriarty, Michelle Flood, Emma Wallace, Susan M. Smith, for the SPPiRE Study team · 2022 · PLoS Medicine
  86. Incidence, characteristics and risk factors of adverse drug reactions in hospitalized children – a prospective observational cohort study of 6,601 admissions
    Signe Thiesen, Elizabeth J. Conroy, Jennifer R Bellis et al. · 2013 · BMC Medicine
  87. Fluoroquinolone Safety in Pediatric Patients: A Prospective, Multicenter, Comparative Cohort Study in France
    Martin Chalumeau, Sylvie Tonnelier, Philippe d’Athis · 2003 · PEDIATRICS
  88. A comprehensive review of swallowing difficulties and dysphagia associated with antipsychotics in adults
    Giuseppe Cicala, María Antonietta Barbieri, Edoardo Spina, José de León · 2019 · Expert Review of Clinical Pharmacology
  89. Cardiovascular Risk Factors in Patients with Lichen Planus
    Salvador Arias‐Santiago, A. Buendía‐Eisman, José Aneiros‐Fernández · 2011 · The American Journal of Medicine
  90. Adverse drug reactions as a cause of hospital admissions: A 6-month experience in a single center in Greece
    Alexandra A. Alexopoulou, Spyridon P. Dourakis, Demosthenes Mantzoukis · 2008 · European Journal of Internal Medicine
  91. Principles and Practices of Medication Safety in the ICU
    Sandra L. Kane‐Gill, Robert James Weber · 2006 · Critical Care Clinics
  92. Psoriasiform Eruption Induced by Infliximab
    M.M. Verea, Jesús del Pozo, Maria Teresa Yebra-Pimentel, Angeles Porta, Eduardo Fonseca · 2003 · Annals of Pharmacotherapy
  93. Impact of the HLA-B58:01 Allele and Renal Impairment on Allopurinol-Induced Cutaneous Adverse Reactions
    Chau Yee Ng, Yu-Ting Yeh, Chuang‐Wei Wang et al. · 2016 · Journal of Investigative Dermatology
  94. The Medication Risk of Stevens–Johnson Syndrome and Toxic Epidermal Necrolysis in Asians: The Major Drug Causality and Comparison With the US FDA Label
    Yu‐Hsin Wang, Chun‐Bing Chen, Wichittra Tassaneeyakul et al. · 2018 · Clinical Pharmacology & Therapeutics
  95. Incidence, causes, and consequences of preventable adverse drug reactions occurring in inpatients: A systematic review of systematic reviews
    Dianna M. Wolfe, Fatemeh Yazdi, Salmaan Kanji, Lisa D. Burry, Andrew Beck, Claire Butler, Leila Esmaeilisaraji, Candyce Hamel, Mona Hersi, Becky Skidmore et al. · 2018 · PLoS ONE
  96. Reporting of adverse drug reactions by nurses
    Sally Morrison–Griffiths, Thomas J Walley, B Kevin Park · 2003 · The Lancet
  97. Possible Association of Acute Lateral-Wall Myocardial Infarction and Bitter Orange Supplement
    Diane L. Nykamp, Majed N Fackih, Anthony L Compton · 2004 · Annals of Pharmacotherapy
  98. Adverse Effects of Voriconazole: Analysis of the French Pharmacovigilance Database
    Céline Eiden, Hélène Peyrière, M. Cociglio, Samira Djezzar, Sylvie Hansel, Jean‐Pierre Blayac, Dominique Hillaire‐Buys · 2007 · Annals of Pharmacotherapy
  99. Drug-Induced Sweet's Syndrome
    Dennis Frank Thompson, Kristin E Montarella · 2007 · Annals of Pharmacotherapy
  100. Drug-induced subacute cutaneous lupus erythematosus: a paradigm for bedside-to-bench patient-oriented translational clinical investigation
    Richard Dennis Sontheimer, Clifford L. Henderson, Renee H. Grau · 2008 · Archives of Dermatological Research